EUVIMEDEUVIMED entdecken
LeserbriefOpen Access · CC BY-NC-ND 4.0

Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor

Thanisha Santhosh, Prakriti Ramamurthy, Vinaya Simha

AACE Endocrinology and Diabetes · 2026-03 · 13 (2) · 270

DOI: 10.1016/j.aed.2026.01.009 ↗

Kurz gefasst

Leserbrief in der Zeitschrift AACE Endocrinology and Diabetes, 2026-03. Verfasst von Thanisha Santhosh und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Endocrinology, Mayo Clinic, Rochester, Minnesota. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Endocrinology, Mayo Clinic, Rochester, Minnesota.
  • Division of Endocrinology, Mayo Clinic, 200 First St SW, Rochester, MN 55905.

Zitieren

APA

Santhosh, T., Ramamurthy, P., & Simha, V. (2026). Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor. AACE Endocrinology and Diabetes, 13(2), 270. https://doi.org/10.1016/j.aed.2026.01.009

Vancouver

Santhosh T, Ramamurthy P, Simha V. Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor. AACE Endocrinology and Diabetes. 2026;13(2):270. doi:10.1016/j.aed.2026.01.009

BibTeX
@article{Santhosh2026,
  author = {Santhosh, Thanisha and Ramamurthy, Prakriti and Simha, Vinaya},
  title = {Safe Use of Metformin in Mitochondrial Diabetes: Response to Letter to Editor},
  journal = {AACE Endocrinology and Diabetes},
  year = {2026},
  volume = {13},
  number = {2},
  pages = {270},
  doi = {10.1016/j.aed.2026.01.009}
}
Kostenlos starten →